609 / 881
German Cancer Consortium (DKTK)
EORTC 22113-08113: LUNGTECH
VU monocenter experience: Data with risk-adapted doses show good local
control rates and moderate toxicity [Haasbeek, J Thor Oncol 2009] :
SBRT: 60 Gy in 8 fractions of 7.5 Gy will be given alternate days,
i.e. over a total treatment time of 2.5 weeks
A study of the EORTC Radiation Oncology and Lung Cancer Groups
EORTC 22113-08113: LungTech
Stereotactic Body Radiotherapy (SBRT) of medically inoperable
patients with centrally located NSCLC
Study Coordinator: Ursula Nestle